OK Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	314.47	277.46	323.03	596.42	599.85
Trading Asset Securities	12.59	13.04	42.31	40.23	44.78
Cash & Short-Term Investments	327.06	290.5	365.34	636.64	644.64
Cash Growth	12.58%	-20.48%	-42.61%	-1.24%	13.75%
Accounts Receivable	383.12	560.19	439.36	383.27	376.79
Other Receivables	26.72	28.31	49.23	26.21	28.11
Receivables	409.84	588.5	488.59	409.47	404.9
Inventory	456	530.54	394.05	422.95	375.64
Prepaid Expenses	-	-	64.47	49.47	57.76
Other Current Assets	56.36	63.13	4.91	7.98	6.06
Total Current Assets	1,249	1,473	1,317	1,527	1,489
Property, Plant & Equipment	2,028	1,627	865.71	874.73	659.4
Long-Term Investments	23.36	22.24	358.92	458.52	482.25
Goodwill	353.52	353.52	23.63	23.63	29.63
Other Intangible Assets	111.56	124.97	1.79	8.95	16.12
Long-Term Deferred Tax Assets	72	62.34	57.11	51.15	44.28
Other Long-Term Assets	11.41	32.39	442.84	117.71	92.09
Total Assets	3,849	3,695	3,067	3,061	2,813
Accounts Payable	140.42	258.32	203.8	244.63	240.4
Accrued Expenses	38.86	44.19	21.31	51.33	26.03
Short-Term Debt	295	305	155.03	185.73	187.04
Current Portion of Long-Term Debt	10.19	55.46	79.62	205.64	142.8
Current Portion of Leases	10.74	3.82	3.19	3.12	2.26
Current Income Taxes Payable	2.24	11.87	-	33.76	-
Current Unearned Revenue	23.04	48.44	90.32	67.83	53.87
Other Current Liabilities	27.13	17.67	24.86	36.14	48.16
Total Current Liabilities	547.6	744.76	578.13	828.18	700.55
Long-Term Debt	606.46	322	91.94	382.97	401.76
Long-Term Leases	90.76	33.77	2.17	3.17	-
Long-Term Deferred Tax Liabilities	25.17	27.85	-	0.43	-
Other Long-Term Liabilities	3.32	0.02	0.02	0.02	7.43
Total Liabilities	1,273	1,128	672.26	1,215	1,110
Common Stock	1,448	1,471	1,458	995.02	949.34
Additional Paid-In Capital	-	-	922.29	600.99	562.02
Retained Earnings	263.7	247.53	158.06	268.07	203.67
Comprehensive Income & Other	801.34	773.95	-140.19	-19.46	-10.52
Total Common Equity	2,513	2,492	2,398	1,845	1,705
Minority Interest	62.93	74.84	-2.76	1.79	-1.5
Shareholders' Equity	2,576	2,567	2,395	1,846	1,703
Total Liabilities & Equity	3,849	3,695	3,067	3,061	2,813
Total Debt	1,013	720.05	331.95	780.63	733.86
Net Cash (Debt)	-686.09	-429.55	33.39	-143.98	-89.22
Net Cash Per Share	-4.70	-2.93	0.26	-1.11	-0.75
Filing Date Shares Outstanding	141.12	143.06	145.77	109.66	104.63
Total Common Shares Outstanding	141.12	143.06	145.77	109.66	104.63
Working Capital	701.65	727.9	739.22	698.33	788.44
Book Value Per Share	17.81	17.42	16.45	16.82	16.29
Tangible Book Value	2,048	2,014	2,372	1,812	1,659
Tangible Book Value Per Share	14.51	14.08	16.28	16.52	15.85
Land	417.61	417.61	417.61	417.61	185.4
Buildings	345.47	345.47	345.04	344.72	343.3
Machinery	342.51	321.15	320.7	286.11	190.59
Construction In Progress	1,124	791.9	20.51	16.01	93.21

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.